The newest evidence changes the practical question around “produce prescriptions” from whether vegetables are healthy to whether a food subsidy, by itself, can measurably improve diabetes control. In a U.S. pragmatic randomized trial published in JAMA Internal Medicine on April 1, 2026, 2,155 adults with diabetes who were at risk for food insecurity were assigned either an $80-per-month debit-card benefit for eligible fruits, vegetables, and legumes or usual care. After 12 months, the intervention did not improve the main clinical outcomes: the adjusted difference in HbA1c was 0.20 percentage points in favor of usual care, and there were no significant differences in emergency-department visits, blood pressure, body-mass index, or inpatient visits.
That result does not show that vegetables are ineffective or that improving diet is unimportant. It shows that the tested delivery model did not produce better diabetes outcomes in that population over one year. Participation was also incomplete: only 433 people, or 30% of those in the intervention group, used at least 80% of the monthly benefit. The trial included people whose average baseline HbA1c was 7.48%, and its comparison was against usual care, with both groups receiving diabetes self-management educational materials. Those details matter because a benefit that is difficult to redeem, insufficient for a household’s food needs, or disconnected from clinical follow-up may not change the overall pattern of eating or medication management.
A second randomized study, published online by Diabetes, Obesity and Metabolism on August 10, 2026, helps explain why programs can look more promising when they include more than a payment mechanism. The Rotterdam pilot enrolled 35 adults with type 2 diabetes, elevated body-mass index, and low socioeconomic status; 17 received weekly plant-based food boxes in addition to dietitian consultations, cooking workshops, and education. Participants collected an average of 10.9 of 12 boxes, or 91%, and attended 1.8 of three workshops, or 59%. The researchers reported favorable exploratory comparisons for dietary intake, weight, body-mass index, and physical quality of life, but no clear between-group difference in glycemic outcomes.
The contrast is useful but should not be overstated. The Dutch study was a small feasibility pilot, not a definitive test of long-term diabetes treatment. Only 11 participants completed the evaluation questionnaire, and the authors described the findings as preliminary evidence requiring adequately powered trials. The U.S. trial was much larger and lasted longer, but it tested a different intervention: a monthly subsidy rather than a structured package of food, instruction, and repeated dietary support. The two studies therefore cannot establish which specific program component caused — or failed to cause — an effect. They do suggest that “free produce” is not a single intervention and that implementation, adherence, and support may be central to outcomes.
Official guidance remains more straightforward about the eating pattern than about prescription programs. In guidance dated May 15, 2024, the U.S. Centers for Disease Control and Prevention says a diabetes meal plan should reflect a person’s goals, tastes, lifestyle, and medicines. It highlights nonstarchy vegetables, fewer added sugars and refined grains, and mostly whole foods. Its plate-method example uses half nonstarchy vegetables, one quarter lean protein, and one quarter carbohydrate foods, while noting that carbohydrate needs should be individualized with a doctor or registered dietitian. This is practical context, not a claim that one plate arrangement will normalize anyone’s blood sugar.
There are also important safety limits. People with diabetes should not use a produce program to replace prescribed medicines, glucose monitoring, or clinical appointments. Changes in food intake can interact with diabetes medicines, and carbohydrate needs differ by treatment, kidney function, pregnancy status, activity, and other conditions. The CDC says that if someone is sick and blood sugar is 240 mg/dL or above, they should check for ketones and contact their doctor if ketones are high; high ketones can signal diabetic ketoacidosis, a medical emergency. Severe vomiting, confusion, trouble breathing, or inability to keep fluids down warrants urgent medical care rather than dietary experimentation.
What happens next is a better test of the idea than another promotional headline: larger trials should compare complete programs with clearly described food benefits, education, cooking support, clinical integration, and redemption data. Researchers should report outcomes beyond short-term food intake, including HbA1c, blood pressure, weight, medication changes, healthcare use, and whether benefits persist after subsidies end. For readers, the evidence supports a modest conclusion: making nutritious food easier to obtain is a reasonable public-health strategy, especially when food insecurity is part of the problem, but a produce prescription should be treated as supportive infrastructure around diabetes care — not as a cure or a substitute for individualized medical advice.